Gensco® Pharma’s abilities provide boundless possibilities for improving health utilizing our unique preparations, innovative dosing methods, and proprietary drug delivery technologies.
Gensco® Pharma has developed and patented a unique transdermal drug delivery system... read more
Gensco® Pharma’s patented topical metered dose applicator dispenses an exact and consistent dose of medication with every pump... read more
Prepare for the flare with the first transdermal treatment for gout flares... read more
The first FDA-approved prescription combination drug-device hydrogel containing Lidocaine 4% HCl for associated pain, wound healing and vasculitis.... read more
Delivers fast controlled pain relief at the site... read more
Non-NSAID alternative for pain, inflammation and bruising. Targeting the source of pain... faster... read more
- June 26 - June 28
- July 16 - July 19
- July 19
- July 21 - July 24
- July 27 - July 30
Go to full list of events here.
Looking To The Future
- Protected: Topical vs Transdermal Lidocaine June 21, 2017 Clinical - Prescription Product Comparison for Intact Skin Product 5% Lidocaine Ointment Lidocaine Patch LiDORx more...
- Physician Explores Gout Treatment Options May 15, 2017 Articles, Clinical, Featured - As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form more...
- The Difference Between Topical and Transdermal Medications March 29, 2017 Clinical, Research - White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract more...
- Working In All Disease States and Cost Management Areas to Help Patients Access Medications March 21, 2017 Clinical, Featured, Industry - Gensco® President and CEO, Carlos Alfaras, recently moderated a Thought Interaction Pod (TIP) session at more...